MOHAMMAD WAHID: Open Payments
NPI 1316715022 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 28 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $242 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 21 | $251 |
| Nalu Medical, Inc. | 1 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| PROTEGA PHARMACEUTIALS INC | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Boston Scientific Corporation | 1 | $19 |
| Averitas Pharma Inc. | 1 | $19 |
Products named: Nalu Neurostimulation System, XTAMPZA, Belbuca, RELISTOR, ROXYBOND, JOURNAVX, Intracept, QUTENZA.
Industry payments across AZ — which companies pay providers there.
